Why Memory Care Residents Are Excluded From Medicare GUIDE in 2026
A 2026 CMS rule change ends GUIDE dementia program eligibility for memory care unit residents and cuts respite funds in assisted living.
FDA-Approved Treatments for Alzheimer’s Agitation in 2026: Auvelity vs Rexulti
Two drugs now hold FDA approval for Alzheimer's agitation — here's how the antipsychotic and its new rival compare on evidence, safety, and side effects.
Auvelity for Dementia Drug Interactions: Bupropion, Dextromethorphan, and MAOI Questions
What families must check before starting Auvelity for Alzheimer's agitation: MAOI washouts, hidden bupropion doubles, and "DM" cough medicines.
PrecivityAD2 vs Lumipulse: How Alzheimer’s Blood Tests Differ
Similar Alzheimer's blood tests can differ substantially in biomarkers, laboratory methods, reporting, regulation, and follow-up.
How Much Does an Alzheimer’s Blood Test Cost and Will Medicare Cover It?
Alzheimer's blood-test bills depend on the assay, medical need, laboratory, and the patient's specific Medicare coverage.
What Can Cause a False Positive or False Negative Alzheimer’s Blood Test?
Kidney disease, early pathology, borderline cutoffs, and sample problems can all distort Alzheimer's blood biomarker results.
What Does a Positive p-Tau217 Alzheimer’s Blood Test Mean?
P-tau217 can reveal Alzheimer's-related biology, but symptoms, context, and confirmatory evidence determine what the result means.
Alzheimer’s Blood Test vs PET Scan vs Spinal Tap: Accuracy and Access Compared
Blood biomarkers improve convenience, but PET and spinal-fluid testing still resolve uncertain or treatment-sensitive cases.
Why the Alzheimer’s Blood Test Is Not a Stand-Alone Diagnosis
A biomarker can reveal Alzheimer's-related biology without proving what is causing a person's cognitive symptoms.
Who Is the FDA-Cleared Alzheimer’s Blood Test Intended For?
Two cleared blood tests serve different ages and stages of cognitive evaluation, with important limits on screening and diagnosis.